Endovascular therapy for M2 segment stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether a minimally invasive procedure to remove a blood clot from a specific branch of a brain artery (the M2 segment) helps people recover from a stroke better than standard care alone. It is for people who have had a moderate to severe stroke within the past 24 hours and could not get clot-dissolving medicine or it didn't work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 84 years old.
- You must have had a recent stroke with a blockage in the M2 branch of the middle cerebral artery (a main brain artery).
- Before the stroke, you were able to do all your usual daily activities without help.
- Your stroke symptoms must be moderate to severe (NIHSS score of 8 or more).
- You must be able to start the procedure within 24 hours of the time you were last known to be well, and within 30 minutes of being assigned to this treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a special catheter system works to remove blood clots from smaller arteries in the brain after a stroke. It aims to see if this treatment helps people recover better.
This study compares two ways of treating an acute ischemic stroke caused by a blockage in a small to medium-sized blood vessel in the brain. One treatment is a minimally invasive procedure to open the blocked vessel (endovascular treatment), and the other is using medications alone (best medical therapy). If you qualify, this study may help determine which approach works better for your situation.
This trial tests a procedure called endovascular therapy (a way to remove the blood clot using a catheter) for people with a severe stroke caused by a large blockage in the back of the brain. The goal is to see if this treatment can improve outcomes compared to standard care.
This Phase 3 trial studies whether removing a clot using a catheter (endovascular thrombectomy) works better for certain types of acute ischemic stroke. It focuses on people with a blocked neck artery plus a blockage in the brain, and who can’t get or didn’t respond to IV clot-busting medicine.
This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.
This trial studies whether an emergency clot-removal procedure through the blood vessels (endovascular treatment) helps people who have a stroke caused by a blocked internal carotid artery in the neck. It compares outcomes in patients treated urgently when imaging shows the blockage is likely the main cause.
Hear when a new Endovascular Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.